Plavix is Associated with Thrombotic Thrombocytopenic Purpura (TTP)


Plavix is a blood thinning medication that is prescribed to prevent heart attacks and stroke in high risk patients, such as those with a history of heart disease. This drug, which is known generically as clopidogrel, has been linked to a number of complications, including cerebral hemorrhaging, gastrointestinal hemorrhaging and other forms of internal bleeding. It is also associated with a serious condition known as thrombotic thrombocytopenic purpura, or TTP.

TTP is a condition that causes many tiny blood clots to form in blood vessels around the body. As such, it can lead to kidney failure, hemorrhaging, stroke, nervous system problems and death if left untreated. Typical signs of TTP include:

  • Headaches
  • Numbness
  • Confusion
  • Difficulty Speaking
  • Paralysis